UNLABELLED: Rapid antigen tests for the detection of SARS-CoV-2 are commonly used for the diagnosis of Covid-19. Previously published data showed a wide range of sensitivity and specificity of RATs, but these studies were performed on relatively small numbers of samples and using only limited numbers of virus variants. The aim of the study was to evaluate the main parameters of a commonly used RAT for 4 different virus variants in comparison with PCR. MATERIAL AND METHODS: A set of 2874 samples obtained from Covid-19 patients were examined both by PCR and RAT. Two commercial PCR kits (Generi Biotech, Diana Biotechnologies) and one RAT - Abbott Panbio™ COVID 19 Ag Rapid - were compared for their sensitivity and specificity in samples positive for one of the four different SARS-CoV-2 variants - B.1.258 (n = 496), Alpha (n = 645), Delta/Delta+ (n = 687), and Omicron (n = 1046). RESULTS: The sensitivity of Panbio™ COVID19 Ag Rapid test varied from 80.0 % in Omicron to 88.92 % in Alpha variants. The specificities of the RAT for all variants reached above 93 %. Statistically significant differences were found between the results from RAT assay in select virus variants. In addition, significantly higher sensitivity (p < 0.05) was detected in samples with higher viral loads than in those with lower. CONCLUSION: Despite the different sensitivity and specificity of Panbio™ COVID19 Ag Rapid test (Abbott ®) for different SARS-CoV-2 variants, this test sensitivity was proven to be always above the 80 % suggested by WHO, which makes it suitable for common use, regardless of the virus variability.

Charles University Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Faculty of Military Health Sciences University of Defence Hradec Kralove Czech Republic

Institute of Clinical Microbiology University Hospital in Hradec Kralove Czech Republic

Zobrazit více v PubMed

Dinnes J., Sharma P., Berhane S., van Wyk S.S., Nyaaba N., Domen J., et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2022;7:CD013705. PubMed PMC

Harvey W.T., Carabelli A.M., Jackson B., Gupta R.K., Thomson E.C., Harrison E.M., et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 2021;19:409–424. PubMed PMC

Wang M.Y., Zhao R., Gao L.J., Gao X.F., Wang D.P., Cao J.M. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front. Cell. Infect. Microbiol. 2020;10 PubMed PMC

WHO . 2021. Antigen-detection in the Diagnosis of SARS-CoV-2 Infection: Interim Guidance.

Torres I., Poujois S., Albert E., Colomina J., Navarro D. Evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clin. Microbiol. Infect. 2021;27:636 e1–e4. PubMed PMC

Linares M., Perez-Tanoira R., Carrero A., Romanyk J., Perez-Garcia F., Gomez-Herruz P., et al. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. J. Clin. Virol. 2020;133 PubMed PMC

Bulilete O., Lorente P., Leiva A., Carandell E., Oliver A., Rojo E., et al. Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care. J. Infect. 2021;82:391–398. PubMed PMC

Villaverde S., Dominguez-Rodriguez S., Sabrido G., Perez-Jorge C., Plata M., Romero M.P., et al. Diagnostic accuracy of the panbio severe acute respiratory syndrome Coronavirus 2 antigen rapid test compared with reverse-transcriptase polymerase chain reaction testing of nasopharyngeal samples in the pediatric population. J. Pediatr. 2021;232:287–289 e4. PubMed PMC

Aguilar-Shea A.L., Vera-García M., Güerri-Fernández R. Rapid antigen tests for the detection of SARS-CoV-2: a narrative review. Atención Primaria. 2021 Nov;53(9) doi: 10.1016/j.aprim.2021.102127. Epub 2021 May 28. PMID: 34217106; PMCID: PMC8162716. PubMed DOI PMC

Nordgren J., Sharma S., Olsson H., Jamtberg M., Falkeborn T., Svensson L., et al. SARS-CoV-2 rapid antigen test: high sensitivity to detect infectious virus. J. Clin. Virol. 2021;140 PubMed PMC

Perez-Garcia F., Romanyk J., Gomez-Herruz P., Arroyo T., Perez-Tanoira R., Linares M., et al. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection. J. Clin. Virol. 2021;137 PubMed PMC

Rodgers M.A., Olivo A., Harris B.J., Lark C., Luo X., Berg M.G., Meyer T.V., Mohaimani A., Orf G.S., Goldstein Y., Fox A.S., Hirschhorn J., Glen W.B., Nolte F., Landay A., Jennings C., Moy J., Servellita V., Chiu C., Batra R., Snell L.B., Nebbia G., Douthwaite S., Tanuri A., Singh L., de Oliveira T., Ahouidi A., Mboup S., Cloherty G.A. Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests. J. Clin. Virol. 2022 Feb;147 doi: 10.1016/j.jcv.2022.105080. Epub 2022 Jan 20. PMID: 35086043; PMCID: PMC8770247. PubMed DOI PMC

Escriva B.F., Mochon M.D.O., Gonzalez R.M., Garcia C.S., Pla A.T., Ricart A.S., et al. The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain. J. Clin. Virol. 2021;143 PubMed PMC

Frediani J.K., Levy J.M., Rao A., Bassit L., Figueroa J., Vos M.B., et al. Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration. Sci. Rep. 2021;11 PubMed PMC

Lim H.J., Park M.Y., Baek Y.H., Lee H.S., Kim I., Kwon Y., You Y., Nam K., Yang J.H., Kim M.J., Yu N., Sohn Y.H., Park J.E., Yang Y.J. Evaluation of four rapid antigen tests for the detection of SARS-CoV-2 infection with nasopharyngeal swabs. Biomedicines. 2023 Feb 24;11(3):701. doi: 10.3390/biomedicines11030701. PMID: 36979680; PMCID: PMC10045780. PubMed DOI PMC

Konstantinus I., Chiwara D., Ndevaetela E.E., Ndarukwa-Phiri V., Garus-Oas N., Frans N., Ndumbu P., Shiningavamwe A., van Rooyen G., Schiceya F., Hlahla L., Namundjebo P., Ndozi-Okia I., Chikuse F., Bantiewalu S.H., Tjombonde K. Laboratory and field evaluation of the STANDARD Q and Panbio™ SARS-CoV-2 antigen rapid test in Namibia using nasopharyngeal samples. PLoS One. 2022 Sep 27;17(9) doi: 10.1371/journal.pone.0269329. PMID: 36166414; PMCID: PMC9514621. PubMed DOI PMC

Osterman A., Badell I., Basara E., Stern M., Kriesel F., Eletreby M., et al. Impaired detection of omicron by SARS-CoV-2 rapid antigen tests. Med. Microbiol. Immunol. 2022;211:105–117. PubMed PMC

Cocherie T., Bastide M., Sakhi S., Zafilaza K., Flandre P., Leducq V., Jary A., Burrel S., Louet M., Calvez V., Marcelin A.G., Marot S. Decreased sensitivity of rapid antigen test is associated with a lower viral load of omicron than Delta SARS-CoV-2 variant. Microbiol. Spectr. 2022 Oct 26;10(5) doi: 10.1128/spectrum.01922-22. Epub 2022 Sep 20. PMID: 36125269; PMCID: PMC9603576.[ PubMed DOI PMC

Anderson M., Holzmayer V., Harris B., Hodges A., Olivo A., Fortney T., Goldstein Y., Hirschhorn J., Pytel D., Faron M.L., Cloherty G., Rodgers M.A. The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays. J. Clin. Virol. 2023 Sep;166 doi: 10.1016/j.jcv.2023.105532. Epub 2023 Jul 6. PMID: 37459763. PubMed DOI

Wertenauer C., Brenner Michael G., Dressel A., Pfeifer C., Hauser U., Wieland E., Mayer C., Mutschmann C., Roskos M., Wertenauer H.J., Moissl A.P., Lorkowski S., März W. Diagnostic performance of rapid antigen testing for SARS-CoV-2: the COVid-19 AntiGen (COVAG) study. Front. Med. 2022 Mar 21;9 doi: 10.3389/fmed.2022.774550. PMID: 35386920; PMCID: PMC8979030. PubMed DOI PMC

Galliez R.M., Bomfim L., Mariani D., Leitão I.C., Castiñeiras A.C.P., Gonçalves C.C.A., Ortiz da Silva B., Cardoso P.H., Arruda M.B., Alvarez P., Brindeiro R., Ota V.A., Rodrigues D.G.M., da Costa L.J., Ferreira O.D.C., Jr., Castiñeiras T.M.P.P., Faffe D.S., Tanuri A. Evaluation of the panbio COVID-19 antigen rapid diagnostic test in subjects infected with omicron using different specimens. Microbiol. Spectr. 2022 Jun 29;10(3) doi: 10.1128/spectrum.01250-22. Epub 2022 Jun 2. PMID: 35652635; PMCID: PMC9241948. PubMed DOI PMC

Acuña-Castillo C., Barrera-Avalos C., Bachelet V.C., Milla L.A., Inostroza-Molina A., Vidal M., Luraschi R., Vallejos-Vidal E., Mella-Torres A., Valdés D., Reyes-López F.E., Imarai M., Rojas P., Sandino A.M. An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile. Front. Public Health. 2023 Jul 10;11 doi: 10.3389/fpubh.2023.1191377. PMID: 37492136; PMCID: PMC10364051. PubMed DOI PMC